483
Continental Services Group, Inc.FDA 483 - Continental Services Group, Inc. - July 09, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Continental Services Group, Inc., a blood bank in Miami, FL, revealed two significant observations. The firm failed to maintain aseptic methods during blood collection, specifically during venipuncture, and also failed to provide adequate private and acoustically protected spaces for donor eligibility examinations.
Open in Dashboard
ID · 0cf3e35c-a346-4edd-a397-675618242d39